Rudat V - Search Results

1

[The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].

Zierhut D, Flentje M, Sroka-Perez G, Rudat V, Engenhart-Cabillic R, Wannenmacher M. Zierhut D, et al. Among authors: rudat v. Strahlenther Onkol. 1997 Feb;173(2):98-105. doi: 10.1007/BF03038929. Strahlenther Onkol. 1997. PMID: 9072845 German.

2

[The belly-board technic for the sparing of the small intestine. Studies on positioning accuracy taking into consideration conformational irradiation technics].

Rudat V, Flentje M, Engenhart R, Metzger M, Wannenmacher M. Rudat V, et al. Strahlenther Onkol. 1995 Aug;171(8):437-43. Strahlenther Onkol. 1995. PMID: 7652666 German.

3

[Three-dimensional planned radiotherapy in rectal cancer. Feasibility study and preliminary clinical results].

van Kampen M, Wulf J, Eble MJ, Rudat V, Gademann G, Schlegel W, Wannenmacher M. van Kampen M, et al. Among authors: rudat v. Strahlenther Onkol. 1995 Feb;171(2):87-93. Strahlenther Onkol. 1995. PMID: 7863431 German.

4

Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer.

Rudat V, Schraube P, Oetzel D, Zierhut D, Flentje M, Wannenmacher M. Rudat V, et al. Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):1027-34. doi: 10.1016/0360-3016(96)00204-0. Int J Radiat Oncol Biol Phys. 1996. PMID: 8751412

5

Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy.

Rudat V, Flentje M, Oetzel D, Menke M, Schlegel W, Wannenmacher M. Rudat V, et al. Radiother Oncol. 1994 Oct;33(1):56-63. doi: 10.1016/0167-8140(94)90086-8. Radiother Oncol. 1994. PMID: 7878210

6

[Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].

Dietz A, Rudat V, Nollert J, Flentje M, Maiei H, Wannenmacher M, Weidauer H. Dietz A, et al. Among authors: rudat v. Laryngorhinootologie. 1996 Dec;75(12):745-53. doi: 10.1055/s-2007-997669. Laryngorhinootologie. 1996. PMID: 9081280 German.

7

Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.

Wenz F, Lohr F, Flentje M, Rudat V, Dietz A, Wannenmacher M. Wenz F, et al. Among authors: rudat v. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):771-6. doi: 10.1016/s0360-3016(97)00024-2. Int J Radiat Oncol Biol Phys. 1997. PMID: 9128950

8

In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer.

Rudat V, Dietz A, Conradt C, Weber KJ, Flentje M. Rudat V, et al. Radiother Oncol. 1997 May;43(2):181-8. doi: 10.1016/s0167-8140(97)01933-6. Radiother Oncol. 1997. PMID: 9192965

9

Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.

Rudat V, Dietz A, Nollert J, Conradt C, Weber KJ, Flentje M, Wannenmacher M. Rudat V, et al. Radiother Oncol. 1999 Dec;53(3):233-45. doi: 10.1016/s0167-8140(99)00149-8. Radiother Oncol. 1999. PMID: 10660204 Clinical Trial.

10

Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer.

Rudat V, Stadler P, Becker A, Vanselow B, Dietz A, Wannenmacher M, Molls M, Dunst J, Feldmann HJ. Rudat V, et al. Strahlenther Onkol. 2001 Sep;177(9):462-8. doi: 10.1007/pl00002427. Strahlenther Onkol. 2001. PMID: 11591019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters